Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06423911
Status:
RECRUITING
Last Update Posted:
2024-05-21
First Post:
2024-05-16
Brief Title:
Study of Olverembatinib HQP1351 in Patients With CP-CML
Sponsor:
Organization:
Ascentage Pharma Group Inc